Overcoming resistance to mTOR inhibition for enhanced strategies in clinical trials

Aung Naing

doi:10.1517/13543784.2013.795947

Overcoming resistance to mTOR inhibition for enhanced strategies in clinical trials

Aung Naing

Investigational Cancer Therapeutics

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	679-685
Number of pages	7
Journal	Expert Opinion on Investigational Drugs
Volume	22
Issue number	6
DOIs	https://doi.org/10.1517/13543784.2013.795947
State	Published - Jun 2013

Keywords

Angiogenesis
MTOR
Phase I
Resistance

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1517/13543784.2013.795947

Cite this

@article{5fe44e21dc9444d2a0bfca601e3014b6,

title = "Overcoming resistance to mTOR inhibition for enhanced strategies in clinical trials",

keywords = "Angiogenesis, MTOR, Phase I, Resistance",

author = "Aung Naing",

year = "2013",

month = jun,

doi = "10.1517/13543784.2013.795947",

language = "English (US)",

volume = "22",

pages = "679--685",

journal = "Expert Opinion on Investigational Drugs",

issn = "1354-3784",

number = "6",

}

TY - JOUR

T1 - Overcoming resistance to mTOR inhibition for enhanced strategies in clinical trials

AU - Naing, Aung

PY - 2013/6

Y1 - 2013/6

KW - Angiogenesis

KW - MTOR

KW - Phase I

KW - Resistance

UR - http://www.scopus.com/inward/record.url?scp=84878234183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878234183&partnerID=8YFLogxK

U2 - 10.1517/13543784.2013.795947

DO - 10.1517/13543784.2013.795947

M3 - Review article

C2 - 23631743

AN - SCOPUS:84878234183

SN - 1354-3784

VL - 22

SP - 679

EP - 685

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

IS - 6

ER -

Overcoming resistance to mTOR inhibition for enhanced strategies in clinical trials

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this